Clinical Trials Logo

Filter by:
NCT ID: NCT05125640 Completed - Pharmacokinetics Clinical Trials

Fasting Bioequivalence Study of 2 Oral Progesterone Soft Capsules 200 mg in 48 Healthy Female Subjects

Start date: December 13, 2019
Phase: Phase 1
Study type: Interventional

This study was designed to assess the bioequivalence of single oral dose of Progesterone 200 mg Soft Capsule (JSC "Farmak", Ukraine) Versus Utrogestan® 200 mg Soft Capsule (Manufacturer by: Cyndea Pharma, S.L., Spain, MAH: Laboratoires Besins International, France) In healthy female subjects under fasting conditions

NCT ID: NCT05125627 Completed - Pharmacokinetics Clinical Trials

Fasting Bioequivalence Study of 2 Progesterone Soft Capsules 200 mg in 66 Healthy Female Subjects Under Vaginal Route

Start date: August 28, 2019
Phase: Phase 1
Study type: Interventional

This study was designed to assess the bioequivalence of Progesterone 200 mg Soft Capsule (JSC "Farmak", Ukraine) versus Utrogestan® 200 mg Soft Capsule (Manufacturer: Cyndea Pharma, S.L., Spain, MAH: Laboratoires Besins International, France) after a single Vaginal dose in healthy female subjects under fasting conditions.

NCT ID: NCT05113810 Recruiting - Clinical trials for 2019 Novel Coronavirus

The Potential Use of Nebulized Hydroxychloroquine for the Treatment of COVID-19

Start date: March 20, 2022
Phase: Phase 2
Study type: Interventional

This is a pilot, randomized, single-center, parallel group, open-label controlled study to evaluate the feasibility, safety, efficacy, and pharmacokinetics of nebulized HCQ01 plus Standard of Care (SOC) versus SOC alone in hospitalized COVID-19 patients. The Jordanian Ministry of Health (MOH) is the study sponsor, and the study will be conducted at MOH COVID-19 hospitals. Approximately 110 patients, ≥18 years of age with a confirmed SARS-CoV-2 infection, will be enrolled and randomized 1:1 to the treatment and control arms where they will receive ten doses of Hydroxychloroquine solution via nebulizer in addition to SOC or the control arm where treatment will follow the MOH SOC.

NCT ID: NCT05106803 Completed - Clinical trials for Surgical Site Infection

Antibiotic Profile of Pathogenic Bacteria Isolated in Public Hospitals in Northern Jordan

Start date: August 1, 2019
Phase:
Study type: Observational

The main aim of the study was to identify the various pathogens associated with surgical site infections and their antibiotic susceptibility in a governmental hospital in northern Jordan.

NCT ID: NCT05101395 Completed - Gastritis Clinical Trials

Prevalence of H. Pylori Gastritis in Sleeve Gastrectomy Specimens

Start date: January 1, 2015
Phase:
Study type: Observational

This is a cross-sectional study looking for prevalence of H.Pylori related gastritis among patients underwent sleeve gastrectomy over five year study period. The study also looks for possible association with patients's characteristics. Also, compares its findings with similar regional and international studies.

NCT ID: NCT05099224 Completed - Nurse's Role Clinical Trials

Mindfulness Meditation for Nursing Students

Start date: October 1, 2020
Phase: N/A
Study type: Interventional

Mindfulness meditation was used to reduce stress and its responses such as cortisol and C-reactive protein (CRP) among healthy and ill individuals in various cultures, but their effects have not yet been studied among Jordanian nursing students, experienced tremendous stress. Thus, the purpose of study was to examine the effects of three of such intervention on perceived stress (MM) on Trait mindfulness, perceived stress, cortisol, and CRP in Jordanian nursing students. The hypothesis was " mindfulness meditation will improve trait mindfulness, perceived stress, serum cortisol and serum CRP. Using a Randomized controlled study conducted in a large university in Jordan, 108 nursing students were randomly assigned to experimental and control groups equally. The experimental group participated in 5 30-minute weekly sessions of mindfulness meditation. Trait mindfulness, perceived stress, serum cortisol, and CRP were measured at baseline and end of intervention.

NCT ID: NCT05087316 Completed - Clinical trials for Mild Obstructive Sleep Apnea

Therapy of Oral Appliance for Adults Jordanians With Obstructive Sleep Apnea

TOAAJOSA
Start date: March 1, 2017
Phase: N/A
Study type: Interventional

Introduction: Obstructive Sleep Apnea (OSA) is the most common form of sleep disordered breathing. Patients who arrive at the dental office with a diagnosis of OSA are often treated with a mandibular advancement device (MAD). A biomimetic oral appliance therapy (BOAT), offers an alternative non-surgical method, which can putatively resolve OSA by combined maxilla-mandibular correction, and addressing craniofacial deficiencies. The aim: To determine whether maxilla-mandibular correction changes induced by BOAT produce a more favorable upper airway, which might result in a reduction in the severity of OSA. Protocol: Adults who underwent an overnight sleep study and were diagnosed by a sleep specialist physician will be potential subjects for the current study. The BQ and EES will be recorded pre- and post- BOAT treatment. Subjects with mild to moderate OSA will have 2 months follow up visits and a final overnight sleep study to measure apnea-hypopnea index (AHI). The subjects will be asked to wear the appliance for 10-12 hours/day and at night. Findings will be analyzed statistically using paired t-tests.

NCT ID: NCT05082753 Completed - Anthelmintic Agent Clinical Trials

Bioequivalence Study to Compare Two Tablets of Ivermectin Tablets (3 mg Ivermectin) Versus Two Tablets of Stromectol ® Tablets (3 mg Ivermectin), in Healthy Subjects Under Fasting Conditions

Start date: November 19, 2020
Phase: Phase 1
Study type: Interventional

Randomized, two-way, two-period, single oral dose, open-label, crossover, bioequivalence study to compare two tablets of Ivermectin tablets (3 mg Ivermectin) versus two tablets of Stromectol ® tablets (3 mg Ivermectin), in healthy subjects under fasting conditions.

NCT ID: NCT05082662 Completed - Analgesic Clinical Trials

Bioequivalence Study to Compare Diclofenac Potassium Coated Tablet Versus Cataflam® 50 Coated Tablet

Start date: August 25, 2020
Phase: Phase 1/Phase 2
Study type: Interventional

Randomized, four-way, four-period, fully-replicated, single oral dose, open-label, crossover, bioequivalence study to compare Diclofenac Potassium coated tablet (50 mg Diclofenac Potassium) versus Cataflam® 50 coated tablet (50 mg Diclofenac Potassium), in healthy subjects under fasting condition

NCT ID: NCT05076968 Completed - Clinical trials for Patient Satisfaction

Patient Satisfaction and Clinical Experience of Dentists

Start date: December 10, 2019
Phase:
Study type: Observational

Rehabilitation of the edentulous patients has always been a challenge. The success of this treatment modality is not only affected by the patients' acceptance of his new dentures, but on his ability to use them which depends to a great extent on the quality of those dentures. It is strongly believed that the success of dental treatments is affected by the experience of a dentist. The aim of this study was to compare patient satisfaction with complete dentures provided by forth and fifth year dental students and prosthodontists at the University of Jordan Hospital one week and 8 weeks post insertion